| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 25mg |
|
||
| 100mg | |||
| Other Sizes |
| ln Vivo |
A single oral dose of Albendazole at 2.5–10 mg/kg in naturally or artificially infected sheep and cattle eliminated 94–100% of gastrointestinal nematodes (Haemonchus, Ostertagia, Trichostrongylus in abomasum; Strongyloides, Nematodirus, Cooperia, Bunostomum, Trichostrongylus, Capillaria, Oesophagostomum, Chabertia in intestines) and reduced Trichuris by 85% at 10 mg/kg.
A single oral dose of 5 mg/kg in sheep and cattle artificially infected with lung nematodes (Dictyocaulus) eliminated 84–100% of the worms. A single oral dose of 10 mg/kg in sheep naturally infected with tapeworms (Moniezia) reduced the worm burden by 100%. A single oral dose of 10 mg/kg in sheep artificially infected with Fasciola hepatica metacercariae eliminated 99% of the liver flukes. Preliminary experiments indicated comparable low doses were effective against various helminths in pigs, horses, and chickens. In mice prophylactically fed Albendazole at 0.05% of the diet for 11 days after oral infection with Ascaris suum ova, the drug protected against the lethal effects of migrating larvae. In dogs, a single oral dose of 250 mg/kg was extremely active against Toxocara canis but only slightly active against Ancylostoma caninum. Administration at 50 mg/kg for 3 days was fully effective against both worms. [1] |
|---|---|
| Animal Protocol |
Sheep and cattle, naturally or artificially infected with various helminths, were given a single oral dose of Albendazole suspended in an unspecified vehicle at doses ranging from 2.5 to 10 mg/kg for gastrointestinal nematodes, 5 mg/kg for lung nematodes (Dictyocaulus), and 10 mg/kg for tapeworms (Moniezia) and liver flukes (Fasciola hepatica).
Sheep artificially infected with Fasciola hepatica metacercariae were treated with a single oral dose of 10 mg/kg after the infection became patent. Mice were orally infected with 50,000 embryonated Ascaris suum ova per day for 2 days and then fed a diet containing 0.05% Albendazole for 11 days prophylactically. Dogs were given a single oral dose of 250 mg/kg or 50 mg/kg/day for 3 days for evaluation against Toxocara canis and Ancylostoma caninum. Efficacy was assessed by worm count reduction at necropsy. [1] |
| Toxicity/Toxicokinetics |
The oral LD50 of albendazole in rats was 2.40 g/kg (95% confidence interval: 1.55 to 3.25 g/kg). No adverse reactions were observed in sheep at oral doses up to 100 mg/kg. Sheep could not tolerate a single dose of 500 mg/kg. Toxicity and teratogenicity studies of this compound are reportedly ongoing. [1]
|
| References | |
| Additional Infomation |
Albendazole is a novel benzimidazole anthelmintic derivative, chemically named methyl [5-(propylthio)-1H-benzimidazole-2-yl]carbamate. It is a stable, white, odorless powder with a melting point of 214–215°C and decomposes. It is insoluble in water and slightly soluble in most organic solvents. It has been reported to be the first anthelmintic effective against major worm parasites (nematodes, tapeworms, and flukes) that threaten livestock. [1]
|
| Molecular Formula |
C12H12D3N3O2S
|
|---|---|
| Molecular Weight |
268.350
|
| Exact Mass |
268.107
|
| CAS # |
1353867-92-1
|
| Related CAS # |
Albendazole;54965-21-8;Albendazole-d7;1287076-43-0
|
| PubChem CID |
71312574
|
| Appearance |
White to off-white solid powder
|
| LogP |
2.9
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
4
|
| Rotatable Bond Count |
5
|
| Heavy Atom Count |
18
|
| Complexity |
291
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
[2H]C([2H])([2H])OC(=O)Nc1[nH]c2ccc(cc2n1)SCCC
|
| InChi Key |
HXHWSAZORRCQMX-BMSJAHLVSA-N
|
| InChi Code |
InChI=1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)/i2D3
|
| Chemical Name |
trideuteriomethyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.7265 mL | 18.6324 mL | 37.2648 mL | |
| 5 mM | 0.7453 mL | 3.7265 mL | 7.4530 mL | |
| 10 mM | 0.3726 mL | 1.8632 mL | 3.7265 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
